CME/CE: Dronedarone in Middle Age Linked to More Admissions

Publication Date:
Fri, 05/01/2015
By: Alere Staff

SPONSORED BY

American Heart Association

MedPage Today

 

ACTIVE DATE

April 3, 2015 – April 3, 2017 

 

CREDIT

Physicians: 0.25 AMA PRA Category 1 Credit(s) ™

 

DESCRIPTION

Treatment with dronedarone (Multaq) was associated with a higher risk for hospitalization than treatment with amiodarone or other antiarrhythmic drugs, in an observational study involving nongeriatric atrial fibrillation (Afib) patients without cardiovascular disease.

 

LINK

http://www.medpagetoday.com/Cardiology/Arrhythmias/50820